BLISS GVS PHARMA Financial Statement Analysis
|
||
|
The Revenues of BLISS GVS PHARMA have increased by 5.13% YoY .
The Earnings Per Share (EPS) of BLISS GVS PHARMA has increased by 52.63 % YoY. |
||
BLISS GVS PHARMA Last 5 Annual Financial Results
[BOM: 506197|NSE : BLISSGVS]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹810 Cr | ₹770 Cr | ₹752 Cr | ₹747 Cr | ₹577 Cr |
| Expenses | ₹683 Cr | ₹620 Cr | ₹634 Cr | ₹629 Cr | ₹471 Cr |
| Operating Profit (Excl OI) | ₹127 Cr | ₹151 Cr | ₹117 Cr | ₹118 Cr | ₹107 Cr |
| Other Income | ₹36 Cr | ₹29 Cr | ₹18 Cr | ₹31 Cr | ₹22 Cr |
| Interest | ₹8.12 Cr | ₹6.91 Cr | ₹10 Cr | ₹4.74 Cr | ₹7.24 Cr |
| Depreciation | ₹29 Cr | ₹26 Cr | ₹19 Cr | ₹17 Cr | ₹17 Cr |
| Profit Before Tax | ₹126 Cr | ₹117 Cr | ₹106 Cr | ₹54 Cr | ₹104 Cr |
| Profit After Tax | ₹90 Cr | ₹82 Cr | ₹77 Cr | ₹23 Cr | ₹74 Cr |
| Consolidated Net Profit | ₹84 Cr | ₹75 Cr | ₹71 Cr | ₹15 Cr | ₹68 Cr |
| Earnings Per Share (Rs) | ₹12.21 | ₹8.00 | ₹7.21 | ₹6.80 | ₹1.45 |
| PAT Margin (%) | 13.91 | 10.71 | 10.59 | 10.21 | 3.09 |
| ROE(%) | 12.11 | 9.01 | 8.89 | 9.11 | 2.88 |
| ROCE(%) | 17.40 | 12.29 | 12.15 | 12.22 | 6.37 |
| Total Debt/Equity(x) | 0.00 | 0.07 | 0.09 | 0.11 | 0.13 |
Key Financials |
||
| Market Cap | : | ₹ 5,627.0 Cr |
| Revenue (TTM) | : | ₹ 927.1 Cr |
| Net Profit(TTM) | : | ₹ 134.7 Cr |
| EPS (TTM) | : | ₹ 12.7 |
| P/E (TTM) | : | 41.8 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| BLISS GVS PHARMA | 1.2% | 29.2% | 240.7% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.4% | 1.2% | 13.8% |
| DIVIS LABORATORIES | -0.5% | -0.6% | 4% |
| TORRENT PHARMACEUTICALS | 2.1% | 1.5% | 42.2% |
| CIPLA | 6.4% | 1.6% | -3.1% |
| DR REDDYS LABORATORIES | 6.2% | 1.6% | 0.2% |
| MANKIND PHARMA | 1.8% | 1.8% | 6.6% |
| LUPIN | -0.4% | 3.5% | 22.5% |
| ZYDUS LIFESCIENCES | 2.9% | 2.1% | 15.7% |
BLISS GVS PHARMA Revenues
[BOM: 506197|NSE : BLISSGVS]
| Y-o-Y | 5.13 % |
| 5 Yr CAGR | 8.83 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹810 Cr | 5.13 | |
| Mar2025 | ₹770 Cr | 2.48 | |
| Mar2024 | ₹752 Cr | 0.55 | |
| Mar2023 | ₹747 Cr | 29.50 | |
| Mar2022 | ₹577 Cr | - | |
BLISS GVS PHARMA Operating Profit
[BOM: 506197|NSE : BLISSGVS]
| Y-o-Y | -15.89 % |
| 5 Yr CAGR | 4.40 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹127 Cr | -15.89 | |
| Mar2025 | ₹151 Cr | 28.38 | |
| Mar2024 | ₹117 Cr | -0.86 | |
| Mar2023 | ₹118 Cr | 10.97 | |
| Mar2022 | ₹107 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -19.99 % |
| 5 Yr CAGR | -4.07 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 15.65% | -19.99 | |
| Mar2025 | 19.56% | 25.30 | |
| Mar2024 | 15.61% | -1.39 | |
| Mar2023 | 15.83% | -14.34 | |
| Mar2022 | 18.48% | - | |
BLISS GVS PHARMA Profit After Tax
[BOM: 506197|NSE : BLISSGVS]
| Y-o-Y | 11.72 % |
| 5 Yr CAGR | 5.33 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹84 Cr | 11.72 | |
| Mar2025 | ₹75 Cr | 6.48 | |
| Mar2024 | ₹71 Cr | 371.14 | |
| Mar2023 | ₹15 Cr | -78.04 | |
| Mar2022 | ₹68 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 29.88 % |
| 5 Yr CAGR | 45.66 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 13.91 % | 29.88 | |
| Mar2025 | 10.71 % | 1.13 | |
| Mar2024 | 10.59 % | 3.72 | |
| Mar2023 | 10.21 % | 230.42 | |
| Mar2022 | 3.09 % | - | |
BLISS GVS PHARMA Earnings Per Share (EPS)
[BOM: 506197|NSE : BLISSGVS]
| Y-o-Y | 52.63 % |
| 5 Yr CAGR | 70.35 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹12 | 52.63 | |
| Mar2025 | ₹8.00 | 10.96 | |
| Mar2024 | ₹7.21 | 6.03 | |
| Mar2023 | ₹6.80 | 368.97 | |
| Mar2022 | ₹1.45 | - | |
BLISS GVS PHARMA Return on Capital Employed (ROCE)
[BOM: 506197|NSE : BLISSGVS]
| Y-o-Y | 41.58 % |
| 5 Yr CAGR | 28.56 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 17.4% | 41.58 | |
| Mar2025 | 12.29% | 1.15 | |
| Mar2024 | 12.15% | -0.57 | |
| Mar2023 | 12.22% | 91.84 | |
| Mar2022 | 6.37% | - | |
BLISS GVS PHARMA Share Price vs Sensex
| Current Share Price | : | ₹530.4 |
| Current MarketCap | : | ₹ 5,627.0 Cr |
| Updated EOD on | : | Jun 29,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 1.2% |
29.2% |
240.7% |
| SENSEX | -0.1% |
1% |
-5.7% |
BLISS GVS PHARMA related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | 2.5% | 3.3% | 14.7% |
You may also like the below Video Courses
FAQ about BLISS GVS PHARMA Financials
How the annual revenues of BLISS GVS PHARMA have changed ?
The Revenues of BLISS GVS PHARMA have increased by 5.13% YoY .
How the Earnings per Share (EPS) of BLISS GVS PHARMA have changed?
The Earnings Per Share (EPS) of BLISS GVS PHARMA has increased by 52.63 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs